![]() CHF Solutions CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients. | ![]() Cardiovascular Systems Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). | ||
Founding Date | Founding Date 2014 | Founding Date 1999 | Founding Date 1989 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Cleveland, US HQ | Locations Eden Prairie, US HQ | Locations Saint Paul, US HQ |
Employees | Employees 2 | Employees 6620% increase | Employees 7257% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.5 m | Valuation ($) 844 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) $236.2m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods $3.1m (FY, 2025) | Cost of goods $63.4m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit $5.1m (FY, 2025) | Gross profit $172.8m (FY, 2022) |
Net income | Net income N/A | Net income ($17.5m) (FY, 2025) | Net income ($36.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 9m | Total funding raised $ 69m |

CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.
View company
Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD).
View company